You are here

  • Home
  • Archive
  • Volume 69, Issue 6
  • Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF
Clinical and epidemiological research
Extended report
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study

Authors

  1. Correspondence to Dr Edward Keystone, University of Toronto and Mount Sinai Hospital, 60 Murray Street, 2nd Floor, Room 2-006, Toronto, Ontario M5G 1X5, Canada; edkeystone{at}mtsinai.on.ca
View Full Text

Citation

Keystone E, Genovese MC, Klareskog L, et al
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study
Annals of the Rheumatic Diseases 2010;69:1129-1135.

Publication history

  • Accepted December 3, 2009
  • First published May 5, 2010.
Online issue publication 
November 02, 2019

Article Versions

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions